The city of Minneapolis, Minnesota, currently has 6 active clinical trials seeking participants for Dementia research studies.
North American Prodromal Synucleinopathy Consortium Stage 2
Recruiting
This study will enroll participants with idiopathic REM sleep behavior disorder (RBD) and healthy controls for the purpose of preparing for a clinical trial of neuroprotective treatments against synucleinopathies.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/22/2024
Locations: University of Minnesota, Minneapolis, Minnesota
Conditions: REM Sleep Behavior Disorder, Parkinson Disease, Lewy Body Dementia, Dementia With Lewy Bodies, Multiple System Atrophy, REM Sleep Parasomnias
Clinical Procedures to Support Research in ALS
Recruiting
The purpose of the Clinical Procedures To Support Research (CAPTURE) study is to utilize information collected in the medical record to learn more about a disease called amyotrophic lateral sclerosis (ALS) and related disorders.
Gender:
All
Ages:
18 years and above
Trial Updated:
03/18/2024
Locations: Hennepin County Medical Center, Minneapolis, Minnesota
Conditions: Amyotrophic Lateral Sclerosis, ALS-Frontotemporal Dementia, Primary Lateral Sclerosis, Progressive Muscular Atrophy
Minnesota Inclusive LTSS for LGBTQ Seniors
Recruiting
This study is designed to help improve the care of sexual and gender minority (SGM) with Alzheimer's Disease and Alzheimer's Disease Related Dementia (AD/ADRD) in long-term services and supports (LTSS) by training the state's LTSS workforce in SGM culturally responsive care. The randomized controlled trial will rigorously test the effects of an in person versus an online training program on improving SGM culturally responsive care with a waitlist control.
Gender:
All
Ages:
18 years and above
Trial Updated:
02/22/2024
Locations: University of Minnesota, Minneapolis, Minnesota
Conditions: Alzheimer Disease, Dementia
Home Alone: An Intervention for People With Cognitive Impairment Who Live Alone
Recruiting
The goal of this clinical trial is to evaluate a program for adults who live alone and have some cognitive impairment (CI) to see if it is useful and acceptable. This program aims to help older adults with cognitive impairment who live alone to be engaged and active, as well as safe at home. The investigators want to see how useful this program is and how it can be improved. The specific aims are: Specific Aim 1: Develop and Adapt Home Alone to Prepare for Pilot Testing. Specific Aim 2: Pilot... Read More
Gender:
All
Ages:
55 years and above
Trial Updated:
02/16/2024
Locations: University of Minnesota, Minneapolis, Minnesota
Conditions: Cognitive Impairment, Dementia, Memory Loss
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
Recruiting
PREVENTABLE is a multi-center, randomized, parallel group, placebo-controlled superiority study. Participants will be randomized 1:1 to atorvastatin 40 mg or placebo. This large study conducted in community-dwelling older adults without cardiovascular disease (CVD) or dementia will demonstrate the benefit of statins for reducing the primary composite of death, dementia, and persistent disability and secondary composites including mild cognitive impairment (MCI) and cardiovascular events.
Gender:
All
Ages:
75 years and above
Trial Updated:
01/17/2024
Locations: Allina Health, Minneapolis, Minnesota +1 locations
Conditions: Cognitive Impairment, Mild, Dementia, Cardiovascular Diseases
The Active Mind Trial: An Adaptive Randomized Trial to Improve Function and Delay Dementia
Recruiting
Older adults at risk for dementia show a variety of cognitive deficits, which can be ameliorated by different cognitive training (CT) exercises. The best combination of CT exercises is unknown. The aim is to discover the most efficacious combination of CT exercises as compared to cognitive stimulation (which will serve as a stringent, active control) to modify the functional trajectories of older adults' with MCI, who are at high risk for dementia. The primary objective of the U01 phase was to d... Read More
Gender:
All
Ages:
Between 55 years and 89 years
Trial Updated:
11/28/2023
Locations: University of Minnesota, Minneapolis, Minnesota
Conditions: Age-related Cognitive Decline, Mild Cognitive Impairment, Dementia